SCHEMBL19000673

SCHEMBL19000673

O=C(/C=C/c1ccc(O)cc1)NCCOCCOCCNC(=O)COC(=O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ POLB P06746 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ ATM Q13315 1/20 0.42
▸ PLEC Q15149 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ FOLH1 Q04609 1/20 0.42
▸ PTGER3 P43115 2/20 0.41
▸ CA9 Q16790 8/20 0.41
▸ CA1 P00915 7/20 0.41
▸ CA2 P00918 7/20 0.41
▸ CA12 O43570 6/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ HTR3A P46098 2/20 0.39
▸ GJA1 P17302 1/20 0.39
▸ GJB2 P29033 1/20 0.39
▸ CA14 Q9ULX7 2/20 0.38
▸ ALPL P05186 1/20 0.38
▸ ALPI P09923 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19000672 0.92 CA12 (0.40) USP2MEN1POLBKMT2AATM
SCHEMBL22007229 0.89 FOLH1 (0.43) USP2MEN1POLBKMT2AATM
SCHEMBL19000669 0.87 ABCB1 (0.55) USP2ATML3MBTL1FOLH1PTGER3
SCHEMBL27057211 0.87 CA9 (0.45) USP2MEN1POLBKMT2AATM
SCHEMBL19000687 0.85 GBA1 (0.44) MEN1KMT2ACA9CA1CA2
SCHEMBL19000689 0.85 FOLH1 (0.39) USP2MEN1POLBKMT2AATM
SCHEMBL22006192 0.83 CA12 (0.41) USP2MEN1POLBKMT2AATM
SCHEMBL19000677 0.83 FTO (0.51) USP2MEN1POLBKMT2AL3MBTL1
SCHEMBL19000681 0.83 TGM2 (0.43) USP2MEN1POLBKMT2A
SCHEMBL27056996 0.81 ALK (0.41) USP2MEN1KMT2AL3MBTL1FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002816-A1 CHROMOGENIC PEROXIDASE SUBSTRATES DAKO DENMARK APS (DK) 2023-01-05 — — US disclosed
US-20170175178-A1 CHROMOGENIC PEROXIDASE SUBSTRATES DAKO DENMARK APS (DK) 2017-06-22 — — US disclosed
US-20170175178-A1 CHROMOGENIC PEROXIDASE SUBSTRATES DAKO DENMARK APS (DK) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170175178-A1 CHROMOGENIC PEROXIDASE SUBSTRATES MPO, TPO, TYR USP2 2528/4885MEN1 3360/4885POLB 1841/4885
US-20230002816-A1 CHROMOGENIC PEROXIDASE SUBSTRATES MPO, TPO, TYR USP2 2385/4885MEN1 3504/4885POLB 1946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback